Skip to main content
NewslettersWatchlist

Stryker Corp(SYK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low389.03
Day High398.20
Open:392.97
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Stryker reports third quarter 2024 operating results
GlobeNewswire
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
MarketBeat
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon
GlobeNewswire
Stryker to announce its third quarter 2024 financial results
Barchart
Stryker - Growth Through Aggressive M&A
Motley Fool
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
Newswire.ca
AI-Driven Cybersecurity Solutions: Innovations Shaping the Future of Data Protection
BayStreet.ca
Federal Agencies Turn to AI for Cybersecurity: Investment Opportunities Explored
MarketBeat
Cardinal Health Soars as America’s Leading Acute Care Supplier
Newswire.ca
Examining the Role of AI in Advancing Healthcare Efficiency
BayStreet.ca
AI's Contribution to Healthcare: Enhancing Patient Care and Operational Efficiency
Newswire.ca
Stryker completes acquisition of MOLLI Surgical
Barchart
A Decade from Now, You'll Wish You Had Bought This Growth Stock
Barchart
Stocks Retreat on the Hawkish FOMC Minutes
Barchart
Stocks Mixed Ahead of Nvidia’s Earnings and Outlook
Barchart
Stocks Pressured from Higher Bond Yields
Barchart
1 'Strong Buy' Growth Stock Wall Street Expects to Soar Around 70%
The Globe and Mail
Top RRSP investment picks from three veteran advisors
Barchart
Stocks Slump as Fed Signals No Rush to Cut Interest Rates
Barchart
Stocks Slide as Tech Earnings Disappoint
Barchart
Markets Today: Tech Earnings Weigh on Stocks as FOMC Results Awaited
MarketBeat
Medtronic: oversold, overextended high yield reversal in play

Profile

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.